Oral Hormone Replacement Therapy Raises Blood Clot Risk
Key Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreKey Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreKey Summary A new study published in npj Women’s Health found that daily physical activity may be linked to estradiol
Read More